Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plakophilin-1 is an armadillo repeat-containing protein localized to both desmosomes and the nucleus, encoded by the PKP1 gene. It is essential for the structural integrity of desmosomal plaques, mediating cell-cell adhesion by linking cadherins (e.g., desmoglein 1) to intermediate filaments (e.g., keratins). Plakophilin-1 plays a pivotal role in desmosome assembly, keratinocyte differentiation, and epidermal morphogenesis. Mutations in PKP1 disrupt desmosome structure, leading to skin fragility syndromes such as ectodermal dysplasia/skin fragility syndrome[1][3][4]. Plakophilin-1 is not a conventional therapeutic target like a receptor or enzyme; its disease associations primarily reflect loss-of-function genetics rather than druggable pharmacology. It is involved in regulation of the actin cytoskeleton and also in control of protein translation and cell proliferation[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plakophilin-1 (PKP1).